Cargando…
Current status of gene therapy for breast cancer: progress and challenges
Breast cancer is characterized by a series of genetic mutations and is therefore ideally placed for gene therapy intervention. The aim of gene therapy is to deliver a nucleic acid-based drug to either correct or destroy the cells harboring the genetic aberration. More recently, cancer gene therapy h...
Autores principales: | McCrudden, Cian M, McCarthy, Helen O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234158/ https://www.ncbi.nlm.nih.gov/pubmed/25419154 http://dx.doi.org/10.2147/TACG.S54992 |
Ejemplares similares
-
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment
por: McCrudden, Cian M., et al.
Publicado: (2017) -
Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs
por: McCrudden, Maelíosa T.C., et al.
Publicado: (2014) -
In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles
por: Kennedy, Joakim, et al.
Publicado: (2017) -
Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer
por: McCrudden, Cian M., et al.
Publicado: (2018) -
COMPLETE BALANCE STUDIES OF NITROGEN, SULPHUR, PHOSPHORUS, CALCIUM, AND MAGNESIUM IN INTESTINAL INFANTILISM
por: McCrudden, F. H., et al.
Publicado: (1912)